- Home
- HWBK vs ABEO Comparison
HWBK vs ABEO Comparison
Compare HWBK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWBK
- ABEO
- Stock Information
- Founded
- HWBK 1865
- ABEO N/A
- Country
- HWBK United States
- ABEO United States
- Employees
- HWBK N/A
- ABEO N/A
- Industry
- HWBK Major Banks
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- HWBK Finance
- ABEO Health Care
- Exchange
- HWBK Nasdaq
- ABEO Nasdaq
- Market Cap
- HWBK 206.5M
- ABEO 243.9M
- IPO Year
- HWBK N/A
- ABEO 1980
- Fundamental
- Price
- HWBK $32.87
- ABEO $5.79
- Analyst Decision
- HWBK
- ABEO Strong Buy
- Analyst Count
- HWBK 0
- ABEO 3
- Target Price
- HWBK N/A
- ABEO $18.00
- AVG Volume (30 Days)
- HWBK 8.7K
- ABEO 286.4K
- Earning Date
- HWBK 01-22-2025
- ABEO 03-17-2025
- Dividend Yield
- HWBK 2.31%
- ABEO N/A
- EPS Growth
- HWBK 1821.83
- ABEO N/A
- EPS
- HWBK 2.61
- ABEO N/A
- Revenue
- HWBK $71,882,000.00
- ABEO N/A
- Revenue This Year
- HWBK N/A
- ABEO N/A
- Revenue Next Year
- HWBK N/A
- ABEO $15,721.96
- P/E Ratio
- HWBK $12.49
- ABEO N/A
- Revenue Growth
- HWBK 36.16
- ABEO 147.52
- 52 Week Low
- HWBK $17.86
- ABEO $3.05
- 52 Week High
- HWBK $34.00
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- HWBK 60.47
- ABEO 48.89
- Support Level
- HWBK $32.05
- ABEO $5.22
- Resistance Level
- HWBK $33.60
- ABEO $5.68
- Average True Range (ATR)
- HWBK 1.03
- ABEO 0.24
- MACD
- HWBK 0.21
- ABEO 0.04
- Stochastic Oscillator
- HWBK 80.95
- ABEO 69.23
About HWBK Hawthorn Bancshares Inc.
Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.